Autologous, ex vivo-expanded tumor-infiltrating T cells that recognize patient-specific tumor neoantigens via native TCRs; after hepatic arterial infusion they home to liver metastases and kill melanoma cells through perforin/granzyme-mediated cytolysis and cytokine release, with expansion/persistence to provide durable anti-tumor immunity.